Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Gil Cunha, De Santis"'
Autor:
Bruno Deltreggia Benites, Mariana Munari Magnus, Lorena Costa, Denise Menezes Brunetta, Roseny dos Reis Rodriges, Susankerle de Oliveira Costa Alves, Gil Cunha De Santis, Silvia Renata Cornélio Parolin Rizzo, Guilherme Rabello, Dante Mario Langhi Junior
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S72-S76 (2024)
Postoperative anemia is a complex clinical issue that requires attention due to its ramifications on the patient's recovery and prognosis. Originating from multiple determinants, such as intraoperative blood loss, hemolysis, nutritional deficiencies,
Externí odkaz:
https://doaj.org/article/7befcdc28a594b8c9c51dcdcd76045a6
Autor:
Gil Cunha De Santis, Lorena Costa, Denise Menezes Brunetta, Mariana Munari Magnus, Bruno Deltreggia Benites, Roseny dos Reis Rodrigues, Susankerle de Oliveira Costa Alves, Silvia Renata Cornélio Parolin Rizzo, Guilherme Rabello, Dante Mario Langhi, Junior
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S67-S71 (2024)
Anemia is a pathological condition in which the hemoglobin and red blood cell mass decrease; it is mainly defined by the concentration of hemoglobin in the blood. The World Health Organization guidelines establish specific values to define anemia in
Externí odkaz:
https://doaj.org/article/86c885af5be04ad4b3667eb467ba57c4
Autor:
Roseny dos Reis Rodrigues, Denise Menezes Brunetta, Lorena Costa, Bruno Deltreggia Benites, Mariana Munari Magnus, Susankerle de Oliveira Costa Alves, Gil Cunha De Santis, Silvia Renata Cornélio Parolin Rizzo, Guilherme Rabello, Dante Mario Langhi Junior
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S77-S82 (2024)
Understanding the physiological concepts of oxygen delivery is essential to discern the mechanisms that influence its increase, reduction or maintenance in the body. This text explores the different mechanisms that help maintain oxygen delivery even
Externí odkaz:
https://doaj.org/article/d41db39694ad4c4ebaccb46777b7e3a0
Autor:
Dante Mário Langhi, Renato Cerqueira de Souza, Melca Barros, Gil Cunha De Santis, Simone Haddad Kashima, Jose Orlando Bordin
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss 1, Pp 100-103 (2022)
Externí odkaz:
https://doaj.org/article/bd68cdd9c8c947338ee2640036fe1e93
Autor:
Camila Derminio Donadel, Bruno Garcia Pires, Nathália Cristine André, Thalita Cristina Mello Costa, Maristela Delgado Orellana, Sâmia Rigotto Caruso, Adriana Seber, Valéria Cortez Ginani, Alessandra Araújo Gomes, Yana Novis, George Maurício Navarro Barros, Neysimélia Costa Vilella, Gláucia Helena Martinho, Ana Karine Vieira, Andrea Tiemi Kondo, Nelson Hamerschlak, Jayr Schmidt Filho, Erick Menezes Xavier, Juliana Folloni Fernandes, Vanderson Rocha, Dimas Tadeu Covas, Rodrigo Tocantins Calado, Renato Luiz Guerino-Cunha, Gil Cunha De Santis
Publikováno v:
Pharmaceuticals, Vol 16, Iss 4, p 512 (2023)
Background: Steroid-refractory acute graft-vs.-host disease (SR-aGVHD) is a complication of allogeneic hematopoietic stem cell transplantation with a dismal prognosis and for which there is no consensus-based second-line therapy. Ruxolitinib is not e
Externí odkaz:
https://doaj.org/article/8b215d26c9fc4c4399a42057c8f205d3
Autor:
Patrícia Oliveira Cunha Terra, Camila Dermínio Donadel, Luciana Correa Oliveira, Mayra Gonçalves Menegueti, Maria Auxiliadora‐Martins, Rodrigo Tocantins Calado, Gil Cunha De Santis
Publikováno v:
Health Science Reports, Vol 5, Iss 2, Pp n/a-n/a (2022)
Abstract Background and Aims Over 4 million deaths from coronavirus disease (COVID)‐19 have been reported in the world. Several biomarkers have been identified that predict disease severity, but there is still a need to identify biomarkers for deat
Externí odkaz:
https://doaj.org/article/eb1ee78381174df19096c75575286705
Autor:
Luciana Ribeiro Jarduli‐Maciel, Júlia Teixeira Cottas de Azevedo, Emmanuel Clave, Thalita Cristina de Mello Costa, Lucas Coelho Marlière Arruda, Isabelle Fournier, Patrícia Vianna Bonini Palma, Keli Cristina Lima, Juliana Bernardes Elias, Ana Beatriz PL Stracieri, Fabiano Pieroni, Renato Cunha, Luiz Guilherme Darrigo‐Júnior, Carlos Eduardo Settani Grecco, Dimas Tadeu Covas, Ana Cristina Silva‐Pinto, Gil Cunha De Santis, Belinda Pinto Simões, Maria Carolina Oliveira, Antoine Toubert, Kelen Cristina Ribeiro Malmegrim
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 4, Pp n/a-n/a (2022)
Abstract Objectives Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is the only currently available curative treatment for sickle cell disease (SCD). Here, we comprehensively evaluated the reconstitution of T‐ and B‐cell compart
Externí odkaz:
https://doaj.org/article/c781cf229ea44de68805e00caa2a983d
Autor:
Júlia Teixeira Cottas de Azevedo, Thalita Cristina de Mello Costa, Keli Cristina Lima, Thiago Trovati Maciel, Patrícia Vianna Bonini Palma, Luiz Guilherme Darrigo-Júnior, Carlos Eduardo Setanni Grecco, Ana Beatriz P. L. Stracieri, Juliana Bernardes Elias, Fabiano Pieroni, Renato Luiz Guerino-Cunha, Ana Cristina Silva Pinto, Gil Cunha De Santis, Dimas Tadeu Covas, Olivier Hermine, Belinda Pinto Simões, Maria Carolina Oliveira, Kelen Cristina Ribeiro Malmegrim
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only currently available curative treatment for sickle cell disease (SCD). However, the effects of HSCT on SCD pathophysiology are poorly elucidated. Here, we assessed red blood ce
Externí odkaz:
https://doaj.org/article/0f750815091a46f1913f64b81244f2f3
Autor:
Rodrigo Nalio Ramos, Virginia Picanço-Castro, Theo Gremen M. Oliveira, Alfredo Mendrone, Junior, Gil Cunha De Santis, Martin Hernan Bonamino, Vanderson Rocha
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S46-S53 (2021)
Chimeric Antigen Receptor T (CAR-T) cells are certainly an important therapy for patients with relapsed and/or refractory hematologic malignancies. Currently, there are five CAR-T cell products approved by the FDA but several research groups and/or b
Externí odkaz:
https://doaj.org/article/558a6b96477e4bcba2af415589f2cdde
Autor:
Gil Cunha De Santis
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S64-S67 (2021)
There are only two ways for a patient to gain access to treatment with an experimental product, such as CAR-T cells: participate in a clinical trial or receive a product in a compassionate basis. In the first case, the main beneficiary is society its
Externí odkaz:
https://doaj.org/article/53365929664a408387f719f8f40220a6